BML Capital Management, LLC
CIK 1616824 · View on SEC EDGAR ↗
- Portfolio value
- $176.1M
- Positions
- 18
- As of
- June 30, 2026
Portfolio value QoQ: +13.0% 13F does not disclose cash
- Top 10 holdings weight
- 93.29%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 13
- Effective number of positions
- 5.4
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 14.55% Est. buys $24,135,588 · sells $28,945,038
Median holding: 3.0 quarters Tracked Q4 2024–Q2 2026 · 36.7% still held
- New positions
- 3
- Increased
- 5
- Decreased
- 3
- Closed
- 1
Put-notional exposure: 0.5% puts 13F reports option positions at underlying notional value — may include hedges, not necessarily bearish bets
On this page
- Performance vs S&P How this manager's 13F portfolio performed against the S&P 500.
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
Performance vs S&P 500
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 98.0% · Options excluded: 1.1%
Sector breakdown
Full portfolio 18 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| ACRS Aclaris Therapeutics, Inc. - Common Stock | $63,347,750 | 35.98% | 11,975,000 | $9,910,250 | Down ×1 | ||
| AVIR Atea Pharmaceuticals, Inc. - common stock | $32,328,335 | 18.36% | 6,952,330 | $-5,647,240 | Down ×2 | ||
| Unknown issuer (CUSIP: 29286X101) | $11,538,941 | 6.55% | 6,669,908 | Up ×1 | |||
| KHC The Kraft Heinz Company - Common Stock | $10,983,300 | 6.24% | 465,000 | $8,172,050 | Up ×1 | ||
| OM Outset Medical, Inc. - Common Stock | $10,885,108 | 6.18% | 2,519,701 | $3,580,656 | Up ×2 | ||
| KMX CarMax Inc | $9,123,525 | 5.18% | 172,500 | $2,678,625 | Up ×1 | ||
| TLYS Tilly's, Inc. Common Stock | $9,030,000 | 5.13% | 2,150,000 | $322,500 | |||
| PMVP PMV Pharmaceuticals, Inc. - Common Stock | $7,142,200 | 4.06% | 5,330,000 | $545,400 | Up ×2 | ||
| TIL Instil Bio, Inc. - Common Stock | $4,964,664 | 2.82% | 645,600 | $-355,080 | |||
| TGT Target Corporation Common Stock | $4,897,875 | 2.78% | 37,500 | $352,875 | |||
| ORMP Oramed Pharmaceuticals Inc. - Common Stock | $4,166,754 | 2.37% | 866,269 | $-6,601,831 | Down ×1 | ||
| JANX Janux Therapeutics, Inc. - Common Stock | $2,380,201 | 1.35% | 154,961 | $226,243 | |||
| PLRX Pliant Therapeutics, Inc. - Common Stock | $1,762,596 | 1.00% | 1,546,137 | $-185,537 | |||
| CNTB Connect Biopharma Holdings Limited - Ordinary Shares | $1,364,423 | 0.78% | 573,287 | $293,139 | Up ×1 | ||
| IMA ImageneBio, Inc. - Common Stock | $1,184,307 | 0.67% | 200,730 | $180,657 | |||
| WMT Walmart Inc. - Common Stock | $386,088 | 0.22% | 335 | Put option | $56,950 | ||
| CORZ Core Scientific, Inc. - Common Stock | $298,000 | 0.17% | 800 | Put option | Up ×1 | ||
| TSLA Tesla, Inc. - Common Stock | $270,000 | 0.15% | 375 | Put option | |||
| No matches | |||||||
Biggest new bets
New positions opened this quarter, largest first.
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| ACRS | Trimmed | -2.3M | +$9.9M |
| KHC | Bought more | +340K | +$8.2M |
| ORMP | Trimmed | -2.3M | -$6.6M |
| AVIR | Trimmed | -106K | -$5.6M |
| OM | Bought more | +618K | +$3.6M |
| KMX | Bought more | +18K | +$2.7M |
| PMVP | Bought more | +10K | +$545K |
| TIL | Price move only | +0 | -$355K |
| TGT | Price move only | +0 | +$353K |
| TLYS | Price move only | +0 | +$322K |
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| SGOV | March 31, 2025 | 260,000 | $26,083,200 | -0.1% |
| ADVM | Dec. 31, 2025 | 3,057,526 | $13,850,593 | No longer tracked |
| ANTX | June 30, 2025 | 5,749,432 | $7,819,228 | 457.1% |
| EPIX | Sept. 30, 2025 | 4,221,546 | $7,176,628 | No longer tracked |
| IKNA | Sept. 30, 2025 | 4,030,102 | $5,400,337 | No longer tracked |
| KZR | June 30, 2026 | 720,787 | $5,348,240 | No longer tracked |
| ALMS | Dec. 31, 2025 | 1,210,415 | $4,829,556 | 142.2% |
| WHWK | June 30, 2025 | 1,890,245 | $3,364,636 | 157.8% |
| LVTX | Dec. 31, 2025 | 1,970,610 | $3,074,152 | No longer tracked |
| MIST | Sept. 30, 2025 | 1,136,091 | $2,204,017 | -45.3% |
| ELEV | Sept. 30, 2025 | 5,890,434 | $2,162,378 | No longer tracked |
| CVNA | March 31, 2026 | 150 | $2,016,000 | -77.7% |
| CNTBXXXX | Sept. 30, 2025 | 1,821,558 | $1,785,127 | No longer tracked |
| TSLA | Sept. 30, 2025 | 200 | $1,654,000 | -22.4% |
| LONA | Dec. 31, 2025 | 323,066 | $1,337,493 | 4.1% |
| ASTC | Dec. 31, 2025 | 220,410 | $1,080,009 | 129.5% |
| SAGE | June 30, 2025 | 135,095 | $1,074,005 | No longer tracked |
| ATHA | Sept. 30, 2025 | 3,230,667 | $975,661 | No longer tracked |
| VTGN | Dec. 31, 2025 | 150,000 | $532,500 | -63.6% |
| PVLA | March 31, 2025 | 42,130 | $505,560 | 415.3% |
| CRVS | Sept. 30, 2025 | 118,766 | $475,064 | 101.6% |
| ARVN | Dec. 31, 2025 | 50,000 | $426,000 | -20.2% |
| TSBX | Sept. 30, 2025 | 1,103,386 | $396,116 | No longer tracked |
| LENZ | March 31, 2025 | 9,271 | $267,654 | -81.3% |
| TSLA | March 31, 2026 | 1,000 | $205,000 | -7.1% |
| HLVX | Sept. 30, 2025 | 91,913 | $182,907 | No longer tracked |
| LSTA | March 31, 2026 | 73,348 | $136,427 | -76.7% |
| NXTC | June 30, 2025 | 273,536 | $131,379 | 17.8% |
| MURA | Dec. 31, 2025 | 57,500 | $119,025 | No longer tracked |
| VRCA | Sept. 30, 2025 | 174,651 | $92,583 | 16.0% |
| ALVR | March 31, 2025 | 184,246 | $77,383 | No longer tracked |
| ACHL | June 30, 2025 | 3,804,921 | $0 | No longer tracked |
| THRD | Dec. 31, 2025 | 3,824,417 | $0 | No longer tracked |